Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Clarus Therapeutics Holdings, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 72.5K | Dec 11, 2021 | Direct | ||
Clarus Therapeutics Holdings, Inc. | Chief Commercial Officer | Common Stock | 29K | Dec 11, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRXT | Clarus Therapeutics Holdings, Inc. | Dec 11, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Chief Commercial Officer |
CRXT | Clarus Therapeutics Holdings, Inc. | Sep 9, 2021 | 0 | $0 | 3 | Sep 13, 2021 | Chief Commercial Officer |